中国保健营养（中旬刊）
中國保健營養（中旬刊）
중국보건영양（중순간）
China Hwalth Care & nutrition
2013年
7期
21-22
,共2页
支气管哮喘%黄芪注射液%CRP%肺功能
支氣管哮喘%黃芪註射液%CRP%肺功能
지기관효천%황기주사액%CRP%폐공능
bronchial asthma%astragalus injection%CRP%pulmonary function
目的：探讨黄芪注射液对支气管哮喘患者的肺功能及血清中CRP的影响。方法：支气管哮喘患者82例，随机分为治疗组和对照组各41例。两组患者均酌情给予常规治疗。治疗组还加用黄芪注射液静滴,每天1次,4周为一疗程。检测两组患者治疗前后血清中CRP及肺功能情况。结果：两组患者治疗前肺功能FEV1占预计值%、PEF 占预计值%：治疗1、4周后，均明显好转(均P<0.05)，治疗组好转情况较对照组更明显(均P<0.05)；两组患者治疗前CRP基本一致( P>0.05)，治疗1、4周后,两组患者CRP均明显下降(均P<0.05),治疗1、4周后比较,两组患者CRP均明显下降(均P<0.05)，但治疗组CRP下降情况较对照组更明显(均P<0.05)；两组治后未发现明显的药物不良反应。结论：黄芪注射液有利于改善哮喘患者的气道应激状态,有利于改善患者的肺功能,安全可靠,值得临床推广使用。
目的：探討黃芪註射液對支氣管哮喘患者的肺功能及血清中CRP的影響。方法：支氣管哮喘患者82例，隨機分為治療組和對照組各41例。兩組患者均酌情給予常規治療。治療組還加用黃芪註射液靜滴,每天1次,4週為一療程。檢測兩組患者治療前後血清中CRP及肺功能情況。結果：兩組患者治療前肺功能FEV1佔預計值%、PEF 佔預計值%：治療1、4週後，均明顯好轉(均P<0.05)，治療組好轉情況較對照組更明顯(均P<0.05)；兩組患者治療前CRP基本一緻( P>0.05)，治療1、4週後,兩組患者CRP均明顯下降(均P<0.05),治療1、4週後比較,兩組患者CRP均明顯下降(均P<0.05)，但治療組CRP下降情況較對照組更明顯(均P<0.05)；兩組治後未髮現明顯的藥物不良反應。結論：黃芪註射液有利于改善哮喘患者的氣道應激狀態,有利于改善患者的肺功能,安全可靠,值得臨床推廣使用。
목적：탐토황기주사액대지기관효천환자적폐공능급혈청중CRP적영향。방법：지기관효천환자82례，수궤분위치료조화대조조각41례。량조환자균작정급여상규치료。치료조환가용황기주사액정적,매천1차,4주위일료정。검측량조환자치료전후혈청중CRP급폐공능정황。결과：량조환자치료전폐공능FEV1점예계치%、PEF 점예계치%：치료1、4주후，균명현호전(균P<0.05)，치료조호전정황교대조조경명현(균P<0.05)；량조환자치료전CRP기본일치( P>0.05)，치료1、4주후,량조환자CRP균명현하강(균P<0.05),치료1、4주후비교,량조환자CRP균명현하강(균P<0.05)，단치료조CRP하강정황교대조조경명현(균P<0.05)；량조치후미발현명현적약물불량반응。결론：황기주사액유리우개선효천환자적기도응격상태,유리우개선환자적폐공능,안전가고,치득림상추엄사용。
Objective: To investigate the effect of Astragalus Injection on pulmonary function and serum in patients with asthma and CRP. Methods: 82 cases of patients with bronchial asthma, were randomly divided into treatment group and control group with 41 cases in each. Two groups of patients were given conventional treatment as appropriate. The treatment group was treated with Astragalus membranaceus injection intravenous drip, 1 times a day, 4 weeks as a course of treatment. Detection of two groups before and after treatment the serum CRP and lung function in. Results:the two groups of patients before treatment of pulmonary function in FEV1 percentage of predicted value%, PEF%predicted:1, 4 weeks after treatment, were significantly improved (P<0.05), the treatment group improved more significantly than that of the control group (al P<0.05);the two groups of patients before treatment CRP basic consistent (P>0.05), 1, 4 weeks after treatment, two groups of patients with CRP were significantly decreased (P<0.05), 1, 4 weeks after treatment, two groups of patients with CRP were significantly decreased (P<0.05), but the treatment group compared with the control group, CRP decreased significantly (P<0.05);the two group after treatment showed no significant adverse drug reactions.Conclusion:Astragalus injection can improve the stress state of the airway in asthma patients, improve lung function, patient safety and reliable, worthy of clinical use.
